Nutrition & Care Q3 2019 The Nutrition & Care segment recorded slight sales growth compared with the prior-year quarter. Considerably higher sales in the Nutrition & Health division more than offset slightly lower sales in the Care Chemicals division. (XLS:) Download Factors influencing sales in Q3 2019 – Nutrition & Care Nutrition & Care Care Chemicals Nutrition & Health Volumes 3% (1%) 12% Prices (2%) (2%) 0% Portfolio 0% 0% 0% Currencies 2% 2% 3% Sales 3% (1%) 15% The positive sales development was primarily attributable to significantly higher volumes in the Nutrition & Health division as a result of improved product availability in the animal nutrition and the flavors and fragrances businesses. This more than offset the slight decline in sales volumes in the Care Chemicals division, especially in the oleo surfactants and alcohols business. Sales were also lifted by currency effects in both divisions. Slightly lower prices in the Care Chemicals division, mainly in the oleo surfactants and alcohols business, had an offsetting effect. By contrast, prices in the Nutrition & Health division were at the level of the prior-year quarter. Overall, income from operations (EBIT) before special items rose considerably year on year. This was largely attributable to a considerable increase in EBIT before special items in the Care Chemicals division due to a contractual one-off payment in the personal care solutions business, as well as higher margins in the oleo surfactants and alcohols business and in the home care, industrial and institutional cleaning and industrial formulators business. By contrast, EBIT before special items declined slightly in the Nutrition & Health division. This was primarily due to higher raw materials prices and fixed costs. Higher earnings contributions from the increase in sales volumes had an offsetting effect. (XLS:) Download Segment data – Nutrition & Care (Million €) Q3 January–September 2019 2018 +/– 2019 2018 +/– a Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments) b Additions to intangible assets and property, plant and equipment Sales to third parties 1,519 1,469 3% 4,575 4,476 2% of which Care Chemicals 1,022 1,037 (1%) 3,121 3,229 (3%) Nutrition & Health 497 432 15% 1,454 1,247 17% Income from operations before depreciation, amortization and special items 331 290 14% 976 945 3% Income from operations before depreciation and amortization (EBITDA) 330 286 15% 956 933 2% Depreciation and amortizationa 106 100 6% 401 287 40% Income from operations (EBIT) 224 186 20% 555 646 (14%) Special items (1) (3) 67% (112) (11) . EBIT before special items 225 189 19% 667 657 2% Assets (September 30) 6,570 6,144 7% 6,570 6,144 7% Investments including acquisitionsb 210 71 196% 419 182 130% Research and development expenses 42 37 14% 115 105 10% back next